Stay updated on Lebrikizumab Long-term Safety Efficacy AD Clinical Trial
Sign up to get notified when there's something new on the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page.

Latest updates to the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6, indicating a new release version. This reflects an updated build/version in the page's documentation.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe header revision tag was updated from v3.6.4 to v3.6.5, signaling a newer build of the page. This is a metadata-level change and does not modify the study information presented.SummaryDifference0.0%

- Check49 days agoChange DetectedA new revision entry, v3.6.4, has been added to replace the previous v3.6.3 in the page's revision history, indicating an updated version of the page. The update does not alter the study details or visible information.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision: v3.6.3 has replaced the previous Revision: v3.6.2 on the page, indicating a platform update.SummaryDifference0.0%

- Check78 days agoChange DetectedA new publication entry is added to Publications detailing a three-year Lebrikizumab extension study with author names; the page revision is updated to v3.6.2, replacing the prior v3.6.0.SummaryDifference0.0%

- Check92 days agoChange DetectedRecruitment status is updated to 'No longer looking for participants', signaling that the study is closed to new participants, and several help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study). Publications references were updated by adding a 2026 Lebrikizumab study citation and removing the older 2025 citation, and the Intervention/Treatment heading formatting was adjusted.SummaryDifference0.1%

Stay in the know with updates to Lebrikizumab Long-term Safety Efficacy AD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page.